Speeding up the translation from bench to bedside
Objective:
Improve the translational approach in research to increase the number of new treatments and prevention strategies that will become available in health care for OA patients.
Task 2.1: Technical and economic hurdles associated with the establishment and implementation of translational research models (crossing the Valley of Death).
Task 2.2: Guidelines for data collection, sampling, phenotyping, endotyping and clinical trial designs for companies bringing products targeting OA to the market to avoid common repeated failures in phase 2 and 3 clinical trials.
Task 2.3: Identification of the major challenges associated with translation from preclinical models to humans without intermediate translational models.
Task 2.4: European Consensus on Chronic Disease Self-Management Program CDSMP program for OA prevention.
Deliverables
On the 22nd of May 2025, at 2pm CET, we had the WG2 Monthly Meeting, that took place online.
During the meeting we had an update of the work being developed in our WG. We work in different subgroups for five manuscripts that at different stages of preparation and one online survey. Several of these projects are now approaching a final stage before submission for publication.
We continued the planning of a Podcast series with different topic suggestions and resources available for recording them, and discussed the possibilities to prepare a joint grant application to Horizon EU funding program.
Finally, we also discussed briefly the next face-to-face meeting that will take place in Porto in September.